No local reports of blood clots linked to vaccines jamaicaobserver.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from jamaicaobserver.com Daily Mail and Mail on Sunday newspapers.
5 Min Read
(Reuters) -Europe’s drug regulator said on Friday it is reviewing rare blood clots in four people in the United States who received Johnson & Johnson’s COVID-19 vaccine.
FILE PHOTO: A nurse draws from a vial of Johnson & Johnson coronavirus disease (COVID-19) vaccine, in Los Angeles, California, U.S., March 25, 2021. REUTERS/Lucy Nicholson/File Photo
The European Medicines Agency’s safety committee has also been looking at how AstraZeneca’s COVID-19 vaccine is associated with very rare cases of unusual blood clots and said it was now reviewing reports of capillary leak syndrome in people given AstraZeneca’s vaccine.
FREDERIC J. BROWN/AFP via Getty Images
European regulators are investigating whether Johnson & Johnson s vaccine could cause blood clots.
The investigation was opened after four cases were reported, including one fatality.
J&J s vaccine was authorized for European distribution last month, but hasn t been given out yet.
European regulators are investigating whether Johnson & Johnson s COVID-19 vaccine caused unusual blood clotting after four cases were reported in vaccine recipients, including one fatality.
The European Medicines Agency s Pharmacovigilance Risk Assessment Committee disclosed Friday that they are reviewing the vaccine after three people who received J&J s vaccine in the US and another who was involved in a clinical trial developed blood clots. It s currently not clear if the vaccine caused these clots.
Don t show me this message again✕
A Johnson & Johnson vaccine dose is administered in Staten Island, New York on Thursday (AP)
The European Union’s drug regulator is reviewing rare blood clots in four people in the United States who received Johnson & Johnson s Covid-19 vaccine.
Johnson & Johnson (J&J) said it was aware of the reported blood clots, and was working with regulators to assess the data and provide relevant information.
“At present, no clear causal relationship has been established between these rare events and the Janssen Covid-19 vaccine,” the company said in an emailed statement.
Of the four serious cases of clotting and low platelets, three occurred in the United States during the rollout of J&J’s Janssen vaccine, the European Medicines Agency (EMA) said. That was in addition to one person who died from a clotting disorder reported in J&J’s clinical trial.
European panel concludes AstraZeneca vaccine is linked to blood clots in rare cases wsws.org - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from wsws.org Daily Mail and Mail on Sunday newspapers.